Literature DB >> 34474108

Activated B Cells and Plasma Cells Are Resistant to Radiation Therapy.

Ida Franiak-Pietryga1, Sayuri Miyauchi1, Sangwoo Shawn Kim1, Philip Dominick Sanders1, Whitney Sumner1, Lin Zhang1, A J Mundt1, Joseph A Califano2, Andrew B Sharabi3.   

Abstract

PURPOSE: B cells play a key role in outcomes of cancer patients and responses to checkpoint blockade immunotherapies. However, the effect of radiation therapy on B cell populations is poorly understood. Here we characterize the effects of radiation on the development, survival, and phenotype of physiological B-cell subsets. METHODS AND MATERIALS: Naïve and immunized tumor bearing and nontumor bearing mice were treated with large-field or focal stereotactic radiation and distinct B-cell subsets of varying developmental stages were analyzed by flow cytometry and real-time reverse transcription polymerase chain reaction.
RESULTS: We first report that focal stereotactic radiation is highly superior to large-field radiation at inducing tumor infiltration of B cells, CD8+ T cells, and macrophages. We observed that radiation affects B cell development in the bone marrow, increasing frequencies of early pro-B cells and late pro-B cells while inducing upregulation of programmed cell death protein 1. We then demonstrate that class switched B cells and plasma cells are highly resistant to radiation therapy compared with naïve B cells and upregulate activation markers programmed cell death 1 ligand 2 and major histocompatibility complex class II) after radiation. Mechanistically, radiation upregulates Xbp1 and Bcl6 in plasma cells, conferring radioresistance. Furthermore, using an immunization approach, we demonstrate that radiation enhances activation-induced cytidine deaminase mediated class switching and somatic hypermutation in primed B cells.
CONCLUSIONS: These data demonstrate that stereotactic radiation is superior to large-field radiation at inducing infiltration of immune cells into tumors and that plasma cells and class switched B cells are highly resistant to radiation therapy. These results represent the most comprehensive analysis of the effects of radiation on B cells to date and identify novel mechanisms by which radiation modulates immune cells within the tumor microenvironment.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34474108      PMCID: PMC8976465          DOI: 10.1016/j.ijrobp.2021.08.037

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   8.013


  57 in total

Review 1.  B cells, plasma cells and antibody repertoires in the tumour microenvironment.

Authors:  George V Sharonov; Ekaterina O Serebrovskaya; Diana V Yuzhakova; Olga V Britanova; Dmitriy M Chudakov
Journal:  Nat Rev Immunol       Date:  2020-01-27       Impact factor: 53.106

2.  Lifetime of plasma cells in the bone marrow.

Authors:  R A Manz; A Thiel; A Radbruch
Journal:  Nature       Date:  1997-07-10       Impact factor: 49.962

3.  Control of B-cell maturation in mice. I. Increased B-cell maturation in vitro by bone marrow protected during whole body irradiation.

Authors:  P P Le Bouteiller; G L Asherson; A J Edwards
Journal:  Immunology       Date:  1981-02       Impact factor: 7.397

4.  Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions.

Authors:  Alexander Filatenkov; Jeanette Baker; Antonia M S Mueller; Justin Kenkel; G-One Ahn; Suparna Dutt; Nigel Zhang; Holbrook Kohrt; Kent Jensen; Sussan Dejbakhsh-Jones; Judith A Shizuru; Robert N Negrin; Edgar G Engleman; Samuel Strober
Journal:  Clin Cancer Res       Date:  2015-04-13       Impact factor: 12.531

5.  Tertiary lymphoid structures improve immunotherapy and survival in melanoma.

Authors:  Rita Cabrita; Martin Lauss; Adriana Sanna; Marco Donia; Mathilde Skaarup Larsen; Shamik Mitra; Iva Johansson; Bengt Phung; Katja Harbst; Johan Vallon-Christersson; Alison van Schoiack; Kristina Lövgren; Sarah Warren; Karin Jirström; Håkan Olsson; Kristian Pietras; Christian Ingvar; Karolin Isaksson; Dirk Schadendorf; Henrik Schmidt; Lars Bastholt; Ana Carneiro; Jennifer A Wargo; Inge Marie Svane; Göran Jönsson
Journal:  Nature       Date:  2020-01-15       Impact factor: 49.962

6.  ZBTB32 is an early repressor of the CIITA and MHC class II gene expression during B cell differentiation to plasma cells.

Authors:  Hye Suk Yoon; Christopher D Scharer; Parimal Majumder; Carl W Davis; Royce Butler; Wendy Zinzow-Kramer; Ioanna Skountzou; Dimitrios G Koutsonanos; Rafi Ahmed; Jeremy M Boss
Journal:  J Immunol       Date:  2012-07-30       Impact factor: 5.422

Review 7.  Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment.

Authors:  Laurel B Darragh; Ayman J Oweida; Sana D Karam
Journal:  Front Immunol       Date:  2019-01-31       Impact factor: 7.561

8.  Tumor-reprogrammed resident T cells resist radiation to control tumors.

Authors:  Ainhoa Arina; Michael Beckett; Christian Fernandez; Wenxin Zheng; Sean Pitroda; Steven J Chmura; Jason J Luke; Martin Forde; Yuzhu Hou; Byron Burnette; Helena Mauceri; Israel Lowy; Tasha Sims; Nikolai Khodarev; Yang-Xin Fu; Ralph R Weichselbaum
Journal:  Nat Commun       Date:  2019-09-02       Impact factor: 14.919

9.  Transitional B cells are the target of negative selection in the B cell compartment.

Authors:  R Carsetti; G Köhler; M C Lamers
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

10.  Defining HPV-specific B cell responses in patients with head and neck cancer.

Authors:  Andreas Wieland; Mihir R Patel; Maria A Cardenas; Christiane S Eberhardt; William H Hudson; Rebecca C Obeng; Christopher C Griffith; Xu Wang; Zhuo G Chen; Haydn T Kissick; Nabil F Saba; Rafi Ahmed
Journal:  Nature       Date:  2020-11-18       Impact factor: 69.504

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.